{"id":"F2006L00988","name":"Therapeutic Goods (Listing) Notice 2006 (No. 3)","slug":"therapeutic-goods-listing-notice-2006-no-3","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":58263,"registerId":"commonwealth-F2006L00988-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2006 (No. 3)","content":"![](image.001.png)\n\nTherapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2006 (No. 3)\n\nI, DAVID GRAHAM, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (ARTG) for listed goods:\n\n-   preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990, for oral use that contain, as a therapeutically active ingredient, Trametes versicolor proteoglycan concentrate, being a substance that is to be mentioned in Division 2 of Part 4 of Schedule 4 of the Therapeutic Goods Regulations 1990.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act this Notice ceases to have effect on the day that amendments to the Therapeutic Goods Regulations 1990 come into effect to require inclusion of the substance(s) listed in this Notice in the part of the ARTG for listed goods.\n\nDated this 28th day of March 2006\n\nDr David Graham\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2580},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The notice maintains a narrow, specific scope limited to the temporary inclusion of a single therapeutic substance in the ARTG for listed goods, exactly as indicated by its title and preamble."},"complexity_factors":["Single specific substance with technical biological nomenclature (Trametes versicolor proteoglycan concentrate)","Temporary legislative mechanism with automatic cessation trigger tied to future regulation amendments","Cross-references to specific provisions of the Act and Regulations (subsection 9A(5), Schedule 4)"],"plain_english_summary":"This notice temporarily permits complementary medicines containing Trametes versicolor proteoglycan concentrate (Turkey Tail mushroom extract) to be lawfully listed and sold in Australia as \"listed goods,\" enabling manufacturers and importers to place these lower‑risk oral supplements on the ARTG immediately. It affects complementary medicine businesses and consumers and operates as a stopgap under the Therapeutic Goods Act 1989 until the Therapeutic Goods Regulations are formally amended."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2006-no-3","history":"/api/acts/therapeutic-goods-listing-notice-2006-no-3/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2006-no-3/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2006-no-3/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2006-no-3/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2006-no-3/documents"}}